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Molecular investigations of Rickettsia helvetica infection in
dogs, foxes, humans and Ixodes ticks
Abstract
Rickettsia helvetica, a tick-borne member of the spotted fever group Rickettsiae, is a suspected pathogen
in humans; however its role in animals is unknown. The aims of this study were to establish a R.
helvetica-specific real-time TaqMan PCR assay and apply it to the analysis of tick vectors (potential
exposure risk) and blood samples from Canidae and humans (prevalence of infection). The newly
designed 23S rRNA gene assay for R. helvetica was more sensitive than a published citrate synthase
(gltA) gene assay for several Rickettsiae. Blood samples from 884 dogs, 58 foxes, 214 human patients
and 2,073 ticks (Ixodes spp.) collected either from vegetation or animals were analyzed. Although the
maximal likelihood estimate of prevalence was 12% in unfed ticks and even 36% in ticks collected from
animals, none of the 1,156 blood samples tested PCR-positive. Ticks from cats were more frequently
PCR-positive than ticks from dogs. Sequencing of the 23S rRNA and/or gltA gene of 17 tick pools
confirmed the presence of R. helvetica. Additionally, R. monacensis that has not been previously
described in Switzerland was identified. In conclusion, R. helvetica was frequently detected in the tick
population, but not in blood samples. Nevertheless, due to the broad host range of the Ixodes ticks and
the high infestation rate with this agent (i.e. R. helvetica was 13-times more frequently in unfed ticks
than the tick-borne encephalitis virus), many mammals may be exposed to R. helvetica. The described
PCR assay represents an important tool to study this topic.
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Rickettsia helvetica, a tick-borne member of the spotted-fever-group rickettsiae, is a suspected pathogen in
humans; however, its role in animals is unknown. The aims of this study were to establish a R. helvetica-specific
real-time TaqMan PCR assay and apply it to the analysis of tick vectors (to determine potential exposure risk) and
blood samples from Canidae and humans (to determine prevalence of infection). The newly designed 23S rRNA gene
assay for R. helvetica was more sensitive than a published citrate synthase gene (gltA) assay for several rickettsiae.
Blood samples from 884 dogs, 58 foxes, and 214 human patients and 2,073 ticks (Ixodes spp.) collected from either
vegetation or animals were analyzed. Although themaximal likelihood estimate of prevalence was 12% in unfed ticks
and 36% in ticks collected from animals, none of the 1,156 blood samples tested PCR positive. Ticks from cats were
more frequently PCR positive than ticks from dogs. Sequencing of the 23S rRNA and/or the gltA gene of 17 tick pools
confirmed the presence of R. helvetica. Additionally, Rickettsia monacensis, which has not been previously found in
Switzerland, was identified. In conclusion, R. helvetica was frequently detected in the tick population but not in blood
samples. Nevertheless, due to the broad host range of Ixodes ticks and the high rate of infestation with this agent
(i.e., R. helvetica was 13 times more frequent in unfed ticks than the tick-borne encephalitis virus), many mammals
may be exposed to R. helvetica. The PCR assay described here represents an important tool for studying this topic.
Tick-borne rickettsioses are caused by intracellular bacteria
belonging to the spotted fever group (SFG) of the genus Rick-
ettsia. The latter comprises more than 20 different species, of
which an increasing number are known to be associated with
human and animal diseases. The SFG rickettsiae are distrib-
uted worldwide, and their distribution depends upon the oc-
currence of tick species. The most common tick in Europe is
Ixodes ricinus, which was found to harbor Rickettsia helvetica.
R. helvetica is transmitted not only transstadially but also
transovarially in I. ricinus. Therefore, this tick is both a vector
and a reservoir for R. helvetica. Due to the broad host range of
I. ricinus, many mammalian species, including humans, can
serve as hosts. Therefore, these host species may potentially be
exposed to R. helvetica. R. helvetica is a suspected pathogen in
humans, and the symptoms described for infections in humans
include fever, headache, arthralgia, and myalgia (1, 3, 7, 21,
34). The agent also has been implicated in two cases of fatal
perimyocarditis (20, 22).
Interestingly, despite the wide distribution of I. ricinus ticks
and the high rate of infection of these ticks with R. helvetica
that has been reported in several European countries (2, 9, 18,
19, 25, 29, 35, 42), larger studies discussing the prevalence of
the infection in humans and animals are scarce. No studies
evaluating the importance of R. helvetica in pets or farm ani-
mals are available as yet. It is unknown whether these animals
can serve as a reservoir or develop clinical signs after infection.
Rickettsial infections have been reported to represent the third
most common vector-borne disease acquired during international
travel and are therefore considered a common cause of fever of
unknown origin in returned travelers (24). As the occurrence of
tick-borne infectious diseases, and particularly rickettsial infec-
tions, is increasing in humans worldwide (26), it may be assumed
that the same holds true for companion animals. In dogs, fever of
unknown origin that is responsive to antibiotic treatment is fre-
quently observed. In these cases, an infectious agent is suspected
but rarely, if ever, confirmed. R. helvetica infections may be the
underlying cause in some of these cases, even if the patient does
not have a travel history, since exposure to R. helvetica-infected I.
ricinus ticks may have occurred locally.
To date, the diagnosis of rickettsial infection has most often
been confirmed by serological testing. However, antibodies are
not detectable prior to the second week of illness for any
rickettsial disease studied thus far. Moreover, except for de-
tection of seroconversion or a fourfold increase in titer, a
positive serology result does not necessarily indicate an acute
infection. A standardized sensitive and specific molecular
method for the confirmation of R. helvetica infections would
facilitate not only its diagnosis but also prevalence studies. This
in turn could increase the awareness of physicians and veteri-
narians who are confronted with diseased individuals.
Therefore, the aims of the present study were as follows:
first, to establish a sensitive real-time PCR assay specific for R.
helvetica; second, to study tick vectors for R. helvetica to assess
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the potential exposure risk for animals and humans; and third,
to evaluate blood samples from Canidae and humans to assess
the occurrence of R. helvetica infections.
(These studies were conducted by A. Perreten as partial
fulfillment of the requirements for a doctoral thesis at the
Vetsuisse Faculty, University of Zurich.)
MATERIALS AND METHODS
Arthropods. To analyze the occurrence of R. helvetica in the Swiss tick pop-
ulation, a total of 2,073 ticks were included in the study. The majority of the ticks
had been described previously (40) and had been microscopically identified
based on their morphology using the key of the University of Neuchatel (6) or
assumed to be members of the genus Ixodes (40). This tick population included
1,880 unfed ticks that had been collected from vegetation in the area around
Zurich (Pfannenstiel, Ku¨snachter Tobel, and Rumensee area), Switzerland, and
188 ticks collected from 39 cats and 66 dogs. In addition, five Ixodes ticks had
been collected from five horses in the Canton of Zurich (Table 1). Furthermore,
to determine the specificity of the newly designed R. helvetica TaqMan PCR
assay, 720 I. ricinus ticks that were collected from vegetation for an unrelated
study and previously differentiated according to sex were also used. They were
randomly chosen from a larger pool of ticks to consist of 480 males and 240
females. All arthropods were stored in liquid nitrogen, at 20°C, or in ethanol
at 4°C until nucleic acids (NA) were extracted.
Blood samples. A total of 1,156 blood samples were included in the study.
They originated from 884 privately owned dogs that were presented for various
reasons at the Clinic for Small Animals, Vetsuisse Faculty, University of Zurich,
58 free-ranging wild foxes, and 214 anonymous human patients (Table 1). The
canine EDTA-anticoagulated blood samples had been described previously (38);
they had been collected throughout a 1-year period. A total of 615 (70%) of the
dogs originated from the Canton of Zurich, Switzerland. The foxes originated
from three different hunting districts in the Canton of Zurich; samples consisted
of coagulated whole blood or serosanguinous fluids. The 214 human EDTA-
anticoagulated blood samples had been provided by a hospital in the Canton of
Zurich and had been collected for diagnostic purposes from presenting patients.
NA extraction. Some ticks were pooled prior to NA extraction, as previously
described (40); the pools consisted of two to ten arthropods of one species
collected from one animal (Table 1). All arthropods, as well as coagulated
whole-blood samples, were mechanically disrupted with sterile scalpel blades and
homogenized in a Mixer Mill MM 300 device (Retsch GmbH, Haan, Germany).
NA extraction was performed with a MagNA Pure LC total NA isolation kit
(Roche Diagnostics, Rotkreuz, Switzerland) or with a DNeasy tissue kit (Qiagen,
Hombrechtikon, Switzerland) (Table 1). From EDTA-anticoagulated blood and
serosanguinous samples, NA was extracted from a volume of 100 l or 200 l
using the MagNA Pure LC total NA isolation kit (38). During each extraction,
negative controls consisting of 200 l phosphate-buffered saline were concur-
rently prepared with each batch of 11 to 15 samples in order to monitor for
cross-contamination.
Eukaryotic NA detection. The presence of amplifiable NA was confirmed for
each sample extracted from ticks using a real-time TaqMan PCR assay specific
for the 18S rRNA gene (Applied Biosystems, Rotkreuz, Switzerland) on a Rotor-
Gene6000 real-time rotary analyzer (Corbett, Mortlake, Australia) using 2
TaqMan fast universal PCR master mix (Applied Biosystems) in a total volume
of 25 l. An initial denaturation step of 20 s at 95°C was followed by 45 cycles of
95°C for 3 s and 60°C for 30 s. In some tick samples, the 18S rRNA assay revealed
unexpectedly high threshold cycle (CT) values (30), which could have been
attributed to inhibition of the PCR. Inhibition was confirmed by testing a 1:10
dilution of the samples; while a CT value approximately 3.3 units higher is
expected for an uninhibited PCR (sample diluted 1:10), the CT values obtained
from some of our samples were lower after dilution. These samples, which
contained substances that inhibited PCRs in their undiluted form, were tested in
a 1:10 dilution in subsequent PCR assays. A representative number of randomly
selected blood samples from human patients (n  50), dogs (n  50), and foxes
(n  15) were also tested for the presence of amplifiable NA. For samples from
humans and foxes, the 18S rRNA real-time PCR assay was used; the canine
samples were analyzed using the canine GAPDH real-time PCR assay (31). No
inhibition of the PCR was found for any of the tested NA samples extracted from
blood samples; the CT values were 22 for all but three samples.
Spotted fever and typhus group Rickettsia gltA real-time PCR assay. Members
of the Rickettsia spotted fever and typhus groups were identified using a previ-
ously published real-time TaqMan PCR assay specific for a 74-bp fragment of the
gltA gene (36). The PCR mixtures contained a final concentration of 0.2 M of
primers (CS-F and CS-R) and probe (CS-P) (Table 2), 12.5 l of 2 TaqMan
fast universal PCR master mix (Applied Biosystems), and 5 l or 2.5 l of
template in a final volume of 25 l. The gltA assay was performed using 60 cycles
on a Rotor-Gene6000 real-time rotary analyzer (Corbett), with an initial dena-
turation step of 20 s at 95°C, which was followed by 60 cycles of 95°C for 3 s and
60°C for 30 s.
Development and specificity of a R. helvetica-specific 23S rRNA real-time PCR
assay. For the detection of R. helvetica, a specific real-time PCR assay based on
a 65-bp fragment of the 23S rRNA (GenBank accession number AY125017) was
designed: this assay amplified a fragment located in the same region as a previ-
ously described real-time PCR (32). The latter assay was not applied in the
present study, because the primer and probe sequences and the conditions of the
PCR assay were not suitable for a standard TaqMan real-time PCR assay per-
formed in ABI real-time cyclers. The system used the primers Rickhelv.147f and
Rickhelv.211r and the probe Rickhelv.170p (Table 2). The real-time PCR mix-
tures contained 12.5 l of the 2 quantitative PCR master mix plus low 5-car-
boxy-X-rhodamine (Eurogentec, Seraing, Belgium), final concentrations of 0.9











% positive by real-time
PCR for:
gltA 23S rRNAgene
Ticks from vegetation 1,880 Vegetation ZH 10 MagNa Pure 9.9c 11.7c
Ticks from animals 71d 39 cats CH/ZHe 1–3 DNeasy 40.9c 49.9c
117f 66 dogs CH/ZHg 1–4 DNeasy 17.6c 28.3c
5 5 horses ZH DNeasy 20 20
Blood samples from animals 884h Dogs CH/ZHi MagNa Pure 0 0
58 Foxes ZH MagNa Pure 0 0
214 Humans ZH MagNa Pure 0 0
a ZH, Canton of Zurich, Switzerland; CH, Switzerland.
b MagNA Pure, MagNA Pure LC total nucleic acid isolation kit (Roche); DNeasy, DNeasy tissue kit (Qiagen).
c Maximal likelihood estimate of prevalence.
d 62 single ticks and three tick pools.
e The majority (83%) of these ticks were collected from cats in the Canton of Zurich.
f 110 out of 117 ticks, as described previously (36); seven additional ticks had been collected from dogs in the Canton of Zurich. In total, 86 single ticks and 12 tick
pools were included.
g The majority (56%) of these ticks were collected from dogs in the Canton of Zurich.
h From the original 889 dogs (38), 884 were included in the study; no sample was available for five dogs.
i The majority (70%) of these blood samples were collected from dogs in the Canton of Zurich.
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M of each primer and 0.25 M of the probe, and 2.5 l or 5 l of the template
in a total volume of 25 l. The R. helvetica-specific real-time PCR assay was
performed using an ABI Prism 7500 fast sequence detection system (Applied
Biosystems), with an initial step of 50°C for 2 min and a denaturation step of
95°C for 10 min, followed by 45 cycles of 95°C for 15 s and 60°C for 1 min. In the
R. helvetica 23S rRNA PCR runs, the amplification mixture contained dUTP for
use with uracil-N-glycosylase in order to prevent the carryover of PCR ampli-
cons. In all the PCR assays, water was used as a negative control. All negative
extraction and pipetting controls were PCR negative. NA from the following
bacteria was used to determine the specificity of the real-time PCR assays: R.
helvetica, Rickettsia africae, Rickettsia conorii, Anaplasma phagocytophilum, Ehr-
lichia canis, Mycoplasma haemofelis, “Candidatus Mycoplasma haemominutum,”
and “Candidatus Mycoplasma turicensis.”
Production of a DNA standard for the 23S rRNA gene of R. helvetica. For
absolute quantification, a 330-bp sequence of the 23S rRNA gene of R. helvetica
(AY125017) enclosing the 65-bp-long sequence detected in the TaqMan system
was amplified using the R. helvetica-specific primers Rhelv.26f and Rhelv.356r
(Table 2). The reaction mixture contained 5 l of 5 Phusion HF buffer
(Finnzymes, Espoo, Finland), 0.5 l of Phusion Hot Start DNA polymerase
(Finnzymes), final concentrations of 0.2 mM deoxynucleoside triphosphates
(dNTPs) and 0.5 M of each primer, and 2.5 l of template NA in a final volume
of 25 l under the following thermal cycling conditions: a denaturation step of
98°C for 3 min followed by 35 cycles of 98°C for 10 s, 65°C for 30 s and 72°C for
1 min, with a final extension of 72°C for 10 min. The amplified fragment was
purified using a Gen Elute PCR cleanup kit (Sigma, Fluka GmbH, Buchs,
Switzerland) and cloned into the TOPO TA cloning vector (Invitrogen, Basel,
Switzerland). Plasmid DNA was purified using a QIAprep spin miniprep kit
(Qiagen), and the insert was verified by sequencing (see below). Purified plasmid
DNA was linearized by restriction digestion using BamHI (Promega, Wallisellen,
Switzerland), purified (QIAquick gel extraction kit; Qiagen), and the copy num-
ber was calculated after both spectrophotometric (GeneQuant; Amersham-Phar-
macia Biotech, Otelfingen, Switzerland) and agarose gel electrophoresis (Gene
Tools; Syngene, Cambridge, United Kingdom) analysis. The R. helvetica DNA
standard was serially 10-fold diluted in a solution containing 30 g/ml of salmon
sperm DNA (Invitrogen), aliquoted, and frozen at 20°C until use.
Efficiency, linearity, and sensitivity of the 23S rRNA gene real-time PCR
assay. For the 23S rRNA assay, the slopes of the dilutions versus CT curves were
assessed for the linear range and as a measure of the amplification efficiency of
the assay. Amplification efficiencies were calculated as (101/slope  1) (14).
Moreover, the standard DNA serial dilutions were used to determine the analytic
sensitivity of the PCR assay in an endpoint dilution experiment and for spike
experiments. For the latter, the dilutions were added to specific-pathogen-free
blood samples prior to NA extraction and real-time PCR, or NA extracted from
blood samples from specific-pathogen-free cats was supplemented with the stan-
dards prior to PCR analysis.
TBEV real-time RT-PCR. For comparison of the prevalence of R. helvetica
with that of another frequently encountered tick-borne pathogen, the 1,880 ticks
collected from the vegetation in the Canton of Zurich were additionally analyzed
by real-time RT-PCR for the presence of the tick-borne encephalitis virus
(TBEV), as previously described (39).
Sequencing of gltA. To confirm the presence of rickettsiae in PCR-positive
samples and analyze the Rickettsia species, sequencing analyses of the gltA gene
were performed (Fig. 1 and Table 2). Initially, for this purpose, a 381-bp PCR
product was amplified using primers that were described previously (27) (Fig. 1
and Table 2) with the following modifications: the reaction mixture contained 2.5
l of 10 PCR TaqGold buffer (Applied Biosystems), 0.4 l of AmpliTaqGold
polymerase (Applied Biosystems), 1.5 l of 25 mM MgCl2, final concentrations
of 0.2 mM of dNTPs and 0.5 M of each primer, and 2.5 l of template DNA in
a total volume of 25 l. The thermal cycling conditions were as follows: an initial
denaturation step of 95°C for 5 min followed by 40 cycles of 95°C for 20 s, 56°C
for 30 s, and 72°C for 1 min, and a final elongation step of 72°C for 5 min. The
PCR products were purified (GenElute PCR cleanup kit; Sigma) and sequenced
using a BigDye Terminator v1.1 cycle sequencing ready reaction kit (Applied
Biosystems). The reaction products were purified using a SigmaSpin postreaction
TABLE 2. Primers specific to the 23S rRNA gene of R. helvetica and the gltA gene of several rickettsiae used in this study
Target, purpose,
and description Primer name Sequence (5–3)
a Reference Ampliconlength (bp)
23S rRNA gene
Real-time PCR
Probe Rickhelv.170p 6FAM-AAC CGT AGC GTA CAC TTA-MGBNFQ This study 65
Forward Rickhelv.147f TTT GAA GGA GAC ACG GAA CAC A This study
Reverse Rickhelv.211r TCC GGT ACT CAA ATC CTC ACG TA This study
Sequencing
Forward rhelv.159f ACG GAA CAC AGA ACC GTA GC This study 206
Reverse rhelv.365r CTG GAT ACC GTG GAT CAA GC This study
Forward rhelv.26f AAT GTG TGT AGC TAA CCG ATA CTA AT This study 330
Reverse rhelv.356r GTG GAT CAA GCC ATG ATA TGA C This study
gltA
Real-time PCR
Probe CS-P FAM-TGC AAT AGC AAG AAC CGT AGG CTG GAT G-BHQ 36 74
Forward CS-F TCG CAA ATG TTC ACG GTA CTT T 36
Reverse CS-R TCG TGC ATT TCT TTC CAT TGT G 36
Sequencing
Forward Rp877p GGG GAC CTG CTC ACG GCG G 27 381
Reverse Rp1258n ATT GCA AAA AGT ACA GTG AAC A 27
Forward CS1f ATG ACT AAT GGC AAT AAT AA 30 496
Reverse CS477r TAA GTT CGT AGT CTG CTT CC 30
Forward CS477f GGA AGC AGA CTA CGA ACT TA 30 796
Reverse CS1273r GAT AAC CAG TGT AAA GCT GT 30
Forward Rp414f AAA CAG GTT GCT CAT CAT TC 33 163
Reverse CS477r TAA GTT CGT AGT CTG CTT CC 30
Forward CS1f ATG ACT AAT GGC AAT AAT AA 30 353
Reverse CS353r GAA TGA TGA GCA ACC TGT TT 30
Forward Rp877p GGG GAC CTG CTC ACG GCG G 27 476
Reverse CS1273r GAT AAC CAG TGT AAA GCT GT 30
a 6FAM, 6-carboxyfluorescein; MGB, minor groove binder; NFQ, nonfluorescent quencher; BHQ, black-hole quencher.
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cleanup kit (Sigma) and run on an ABI Prism 310 genetic analyzer (Applied
Biosystems).
In addition, a longer portion of the gltA gene was sequenced using five addi-
tional published gltA-specific PCR assays (27, 30, 33). The primer sequences,
lengths of the five PCR products, and corresponding references are provided in
Fig. 1 and Table 2. The reaction mixture for the five systems contained 5 l of 5
Phusion HF buffer (Finnzymes), 0.5 l of Phusion Hot Start DNA polymerase
(Finnzymes), final concentrations of 0.2 mM of dNTPs and 0.5 M of each
primer, and 1.25 l of template NA in a final volume of 25 l under the following
thermal cycling conditions: initial denaturation step of 95°C for 2 min followed
by 40 cycles of 95°C for 30 s, 45°C for 30 s, and 65°C for 55 s and a final
elongation step of 72°C for 3 min (27).
Sequencing of the 23S rRNA gene. In order to further confirm the specificity
of the newly established R. helvetica 23S rRNA TaqMan assays, for the produc-
tion of the standard, and also to confirm PCR-positive results, two partially
overlapping fragments of 206 and 330 bp were amplified. The primers (Table 2)
for these assays were designed as follows: for the 206-bp fragment, both primers
(Rhelv.159f and Rhelv.365r) were based upon the R. helvetica (AY125017) se-
quence. However, this fragment does not fully enclose the TaqMan sequence.
For the fragment of 330 bp, which encloses the complete TaqMan system, a R.
helvetica specific reverse primer, R.helv.356r, was used (Table 2). The forward
primer, Rhelv.26f, was based upon a Rickettsia consensus sequence. The reaction
mixture and thermal cycling conditions were the same as those described above
for production of the standard. The PCR products were sequenced as described
above for the gltA gene, using the PCR amplification primers.
Phylogenetic analyses. Phylogenetic and molecular evolutionary analyses were
conducted using MEGA version 3.1 (16). The sequences obtained were com-
pared to known sequences deposited in the GenBank database, and the percent
identity was calculated by pairwise comparison (Kimura two-parameter model)
(13). The sequences were aligned using CLUSTAL W (37) and manually ad-
justed. Only positions where the nucleotide composition was known in all of the
sequences being compared were used in the phylogenetic analysis. The phylo-
genetic tree was constructed after trimming of the primer sequences by the
neighbor-joining method (28) from a distance matrix corrected for nucleotide
substitutions by the Kimura two-parameter model. The data set was resampled
1,000 times to generate bootstrap values.
Statistics. The maximal likelihood estimate of prevalence and the 95% con-
fidence intervals (CI) were calculated as described previously (41) using the
open-source program R (http://www.r-project.org/). This program allows the
calculation of prevalence data from samples consisting of single ticks only or tick
pools only but also from samples containing single ticks and tick pools combined.
The rickettsial loads of the female and male tick pools were compared using the
Mann-Whitney U test (4); the NA content of each pool was controlled using an
18S rRNA gene assay. The frequencies of PCR-positive results for ticks collected
from cats and those for ticks collected from dogs were compared using the 2 test
(4). Ticks from horses were not included in this analysis because of the small
number of ticks (n  5).
Nucleotide sequence accession numbers. The partial gltA/23S rRNA gene
nucleotide sequences generated from R. helvetica isolates have been submitted to
GenBank and given the accession numbers EU359279 to EU359283, EU359285
to EU359297, and EU359301 for gltA and EU359273 to EU359278 for the 23S
rRNA gene. In addition, sequences for tick pool 73 have been submitted to
GenBank and given the accession numbers EU359284, EU359298 to EU359300,
and EU359302.
RESULTS
Specificity of the 23S rRNA gene real-time PCR assay. A
new real-time PCR assay for the detection and quantification
of the 23S rRNA gene of R. helvetica was designed in this
study. To test the specificity of the PCR assay, NA of various
bacteria (see Materials and Methods) were analyzed. They all
tested negative by real-time PCR, with the exception of R.
helvetica. To confirm that the PCR system did not amplify
endosymbionts, which are present only in female ticks, 24 tick
pools consisting of 20 male ticks and 24 pools containing 10
female ticks were assayed. All pools tested positive using the
23S rRNA real-time PCR assay. No significant differences
were found in the rickettsial NA load between the female and
male tick pools using the 23S rRNA real-time PCR assay for
quantification (data not shown). To further confirm the spec-
ificity of the assay and PCR-positive results, five 23S rRNA
gene TaqMan PCR-positive I. ricinus tick pools collected from
vegetation were sequenced (four PCR products of 206 bp and
two PCR products of 330 bp) (Table 2). All resulting se-
quences were 100% similar to that of R. helvetica (AY125017).
Linear range of amplification and sensitivity of the real-
time PCR assay. The 23S rRNA gene R. helvetica DNA stan-
dard was serially 10-fold diluted to assess the linear range and
sensitivity of the assay. The amplification of the serial dilutions
showed linearity over 8 orders of magnitude and a mean effi-
ciency of the assay of 98.8%. The highest dilution still yielding
a positive signal contained an average of one copy of the
standard per reaction; in an endpoint dilution experiment, six
out of eight replicates (75%) of this dilution were positive. In
the spike experiments, between one and ten copies of the DNA
standard were detectable when the DNA standard was added
to blood or to NA samples prior to processing. This calculated
a lower detection limit of 100 to 2,000 copies/ml of blood,
depending on the extraction procedures.
Rickettsiae in arthropods collected from vegetation. The
NA from 188 tick pools collected from vegetation in the area
around Zurich, Switzerland, were analyzed by the gltA real-
time PCR for the presence of rickettsiae of the SFG and
typhus group: 122 of the 188 pools tested positive. This re-
sulted in a maximal likelihood estimate of the prevalence of
spotted fever and typhus group rickettsiae of 9.9% (95% CI,
8.3 to 11.8%) (Table 1).
In addition, arthropods were analyzed by the 23S rRNA gene
real-time PCR for the presence of R. helvetica NA. When unfed
ticks from Swiss vegetation were analyzed, the majority of the
pools (134 out of 188) were found to be positive for the 23S rRNA
gene. This resulted in a maximal likelihood estimate of prevalence
of R. helvetica in the Swiss I. ricinus tick population under inves-
tigation of 11.7% (95% CI, 9.9 to 13.8%) (Table 1).
The readout of the real-time PCR assays, e.g., the 23S rRNA
gene and gltA gene assays, is the so-called CT value. The CT
value is an inverse measure of the template load; the higher the
template load, the lower the CT value. Analyzing the 188 tick
pools from the vegetation, all of the CT values from the gltA
gene real-time PCR assay were higher than the CT values from
the 23S rRNA gene real-time PCR assay, except for one tick
FIG. 1. Schematic diagram of the sequencing procedures for the
gltA gene. The amplification of seven different amplicons was at-
tempted. For sequencing primers, see Table 2.
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pool, no. 73. Twelve pools tested positive in the 23S rRNA
assay but negative in the gltA assay. Tick pool 73 and some
additional pools were analyzed further by sequencing.
For comparison, the 188 tick pools were also analyzed for
TBEV: 16 of 188 pools tested positive. This resulted in a
maximal likelihood estimate of prevalence of 0.9% (95% CI,
0.5 to 1.4%).
Rickettsiae in arthropods collected from animals. Overall,
43 out of 153 ticks and 6 out of 15 tick pools tested real-time
PCR-positive with the gltA-specific TaqMan PCR system. This
resulted in an overall maximal likelihood estimate of preva-
lence of 26.2% (95% CI, 20.2 to 32.8%). When the samples
were classified according to the animal species they had been
collected from, 26 out of 62 ticks and two out of three tick
pools from cats were found to be PCR positive. This resulted
in a sample prevalence of rickettsiae of the spotted fever and
typhus groups in ticks from cats of 40.9% (95% CI, 29.8 to
52.9%) (Table 1). Ticks from 18 out of 39 cats were found to
be gltA PCR positive. For ticks collected from dogs, 16 out of
86 ticks and 4 out of 12 pools were positive. The maximal
likelihood estimate of prevalence in ticks from dogs was 17.6%
(95% CI, 11.4 to 25.3%) (Table 1). Ticks collected from 18 out
of 66 dogs tested PCR positive. One out of five ticks collected
from horses was positive. Ticks collected from cats were sig-
nificantly more frequently gltA PCR positive than ticks col-
lected from dogs (P [2]  0.0019). In addition, ticks from a
higher percentage of cats than of dogs were PCR positive (P
[2]  0.0489).
Overall, 57 out of 153 ticks and 9 out of 15 tick pools
collected from animals tested real-time PCR positive for the
23S rRNA gene of R. helvetica. This resulted in an overall
maximal likelihood estimate of prevalence of 36.1% (95% CI,
29.4 to 43.3%). When the samples were classified according to
the animal species from which they were collected, 32 out of 62
ticks and two out of three pools containing three ticks per pool
collected from cats were positive; the overall sample preva-
lence for ticks from cats was 49.9% (95% CI, 38.1 to 61.7%)
(Table 1). Ticks from 21 out of 39 cats tested PCR positive. In
ticks from dogs, 24 out of 86 ticks and 7 out of 12 tick pools
tested PCR positive. The maximal likelihood estimate of prev-
alence in ticks from dogs was 28.3% (95% CI, 20.4 to 37.2%)
(Table 1). Ticks collected from 27 out of 66 dogs tested PCR
positive. One out of five ticks collected from horses was PCR
positive. Ticks collected from cats were significantly more fre-
quently 23S rRNA gene PCR positive than ticks collected from
dogs (P [2]  0.0033).
Again, the CT values for the 23S rRNA assay were, with one
exception (tick 17), lower than those for the gltA assay; 17 samples
tested positive using the R. helvetica-specific 23S rRNA assay but
negative in the gltA assay. Tick 17 could not be analyzed further
by sequencing due to a low bacterial load. It originated from a
9-year-old Japanese Chin dog from the Canton of Zurich.
Rickettsiae in blood samples from dogs, foxes, and human
patients. All 1,156 NA samples extracted from blood from
dogs, foxes, and human patients in Switzerland tested negative
in the gltA and the 23S rRNA gene real-time PCR assays.
Sequencing results from rickettsiae detected in ticks. To
confirm the gltA PCR-positive results and to determine the
Rickettsia species, different fragments of the gltA gene were
sequenced. A 381-bp-long PCR product (Table 2 and Fig. 1)
was amplified from 10 PCR-positive tick pools collected from
the vegetation. Nine out of the ten pools yielded a sequence
with 100% identity to that of R. helvetica (AM418450). In
contrast, sequencing of the 10th pool, tick pool 73, resulted in
a sequence with 16 mismatches to R. helvetica (AM418450).
This sequence was most closely related (98 to 99% identity) to
the following Rickettsia species: Rickettsia sp. strain IRS4
(AF141906), found in I. ricinus in Slovakia; Rickettsia mona-
censis (DQ100163), reported in Germany; and Rickettsia sp.
strain PoTiR6dt (EF501756), from I. ricinus in Portugal.
For tick pool 73 and four additional tick pools (pools 15, 20,
21, and 41), several other fragments could be amplified and
sequenced. For all five pools, the 163-bp PCR product was
amplified, and for all but pool 15, the 796-bp fragment was
amplified (Fig. 1 and Table 2). Moreover, for three ticks, the
476-bp fragment was amplified, and for tick pool 15, the 353-bp
PCR product was successfully amplified (Fig. 1 and Table 2).
The sequences from the additional four tick pools (pools 15,
20, 21, and 41) were most similar (98 to 99%) to R. helvetica
(U59723). However, tick pool 73 had 34 mismatches to the R.
helvetica (U59723) sequence and was most closely related
(99%) to Rickettsia sp. strain IRS3 (AF140706) and Rickettsia
sp. strain IRS4 (AF141906), found in I. ricinus ticks collected
in Slovakia, and R. monacensis (DQ100163), which has been
reported in Germany.
Phylogenetic analyses. Phylogenetic analyses were per-
formed based on the 348-bp-long sequence of the gltA gene of
14 sequenced tick pools (Fig. 2). These sequences were ob-
tained from 10 tick pools after amplification of the 381-bp
fragment, from three tick pools after amplification of the
796-bp PCR product, and from one tick pool after amplifica-
tion of the 476-bp fragment. Thirteen out of 14 sequences
clustered with R. helvetica (U59723). Only tick pool 73
branched away from the remaining sequenced tick pools, and
sequences from this pool were most closely related to R. mo-
nacensis (DQ100163), Rickettsia sp. strain IRS4 (AF141906),
and Rickettsia sp. strain PoTiR6dt (EF501756) (Fig. 2).
DISCUSSION
This study expands our knowledge of the distribution of R.
helvetica infection in ticks, foxes, dogs, and human patients
within a geographical region by employing a newly developed
sensitive real-time TaqMan PCR assay. We concentrated on
the investigation of humans and Canidae, because both are
known to develop disease when infected with SFG rickettsiae.
Despite the fact that R. helvetica was frequently detectable in
Ixodes ticks, none of the 1,156 blood samples tested positive.
Nonetheless, ticks collected from animals, and particularly
from cats, were more frequently positive than those collected
from vegetation. With one exception, all identified rickettsiae
were assumed to be R. helvetica. In addition, R. monacensis,
which to our knowledge had not been previously detected in
Switzerland, was identified according to the sequencing results.
The real-time TaqMan PCR assay developed in this study
amplifies a fragment of the 23S rRNA gene of R. helvetica. A
recently described assay for the R. helvetica 23S gene (32)
could not be used in the present study because the oligonucle-
otide sequences and the run conditions were not compatible
with a standard TaqMan assay on our ABI real-time cyclers.
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Our newly designed PCR system did not amplify endosymbi-
onts; the latter is of major concern in the development of
diagnostic PCR assays for rickettsial and related agents. The
assay was found to be more sensitive for the detection of R.
helvetica than a previously described real-time TaqMan assay
that detects the gltA gene of rickettsiae of the spotted fever and
typhus groups (36). This observation may be explained by the
higher specificity of the primers and probe for R. helvetica in
the newly designed assay compared to the more generic pub-
lished assay (36). The latter assay was demonstrated to have
FIG. 2. Bootstrap phylogenetic tree of 14 partial gltA sequences from tick pools (1,000 bootstrap resamplings). Only bootstrap values of 	70%
are shown. The bar represents the mean number of differences per 100 sites. Sequences of 10 tick pools (EU359288, EU359290 to EU359292,
EU359294 to EU359297, EU359301, and EU359302) were derived from a 381-bp PCR fragment, three other pools (EU359285 to EU359287) from
a 796-bp PCR fragment, and one pool (EU359289) from a 476-bp PCR fragment.
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three mismatches in the target sequence (36), which may lead
to a reduced efficiency (15) and in turn to a lower sensitivity of
the assay. Thus, for the most sensitive detection of R. helvetica
the 23S rRNA gene assay should be used, because with the gltA
assay, the prevalence of R. helvetica could be underestimated.
The CT difference between the two assays (23S RNA gene
and gltA) could be used as a marker for the presence of R.
helvetica compared to other Rickettsia species. Samples with
lower CT values for the 23S rRNA gene than for the gltA gene
were identified as R. helvetica (n 16) by sequencing. Remark-
ably, the one sample with a higher CT value in the 23S rRNA
assay was a Rickettsia species that had not been previously
reported in Switzerland. Therefore, although the 23S rRNA
gene PCR assay was designed to specifically amplify only R.
helvetica, other rickettsiae, in particular uncharacterized
strains, may also be amplified; however, the efficiency at which
this would be expected to occur would probably be low. We
suggest using the above-mentioned method of comparison of
CT values resulting from the two TaqMan PCR assays (23S and
gltA) for screening purposes and further confirmation of dis-
cordant samples by sequencing. The estimated prevalence of
R. helvetica in approximately 2,000 analyzed ticks was between
10% and 40%. This was confirmed by sequence analyses, and
R. helvetica was the only detected rickettsial agent, with the
exception of one positive tick pool sample that revealed a
different Rickettsia species. Its sequence was most closely re-
lated to those reported from ticks from Portugal (EF501756.1;
Rickettsia sp. strain PoTiR6dt), Slovakia (AF141906.1; Rickett-
sia sp. strain IRS4), and Germany (DQ100163.1; R. monacen-
sis). This observation is in accordance with other results re-
cently obtained in Germany: R. monacensis was isolated and
characterized from I. ricinus ticks collected in Upper Palatine
in southeastern Germany. The Rickettsia species was identified
by sequencing the genes gltA, rompA, and rompB. Based on the
data obtained, an identity of	99% between R. monacensis and
Rickettsia strains IRS3 and IRS4 was observed (R. Wo¨lfel,
personal communication). The results show that R. monacensis
has a much larger area of distribution than previously believed.
Furthermore, molecular characterization indicates that R. mo-
nacensis and the Rickettsia strains IRS3 and IRS4 belong to a
single species.
The investigation of tick populations may be used as an
epidemiological tool to determine the importance of an infec-
tious agent in a specific area. A high percentage of I. ricinus
ticks collected from vegetation were found to be PCR positive
for R. helvetica. Interestingly, the estimated prevalence was
higher in ticks collected from animals than in ticks collected
from vegetation. Our results are in agreement with a study
from Denmark by Nielsen and coworkers (18), in which the
presence of R. helvetica was highest in adult ticks collected
from dogs and roe deer. These findings may indicate that large
mammals act as reservoir hosts for R. helvetica, an assumption
which is further supported by a study from Inokuma and co-
workers (10). Those authors analyzed blood samples collected
from sika deer in Japan and found that 8 out of 102 animals
were PCR positive for R. helvetica. Since deer are often in-
fested with high numbers of ticks, they can be an important
reservoir for tick-borne pathogens. Remarkably, in the present
study, more of the ticks from cats than from dogs were PCR
positive for R. helvetica. For all the ticks collected from cats,
the CT values were lower in the 23S rRNA PCR assay than the
gltA assay. From an ongoing study, we know that Rickettsia felis,
which could potentially be found in feline samples but has not
been detected in Switzerland as yet, had a higher CT value in
the 23S rRNA assay than in the gltA assay (S. Hornok, personal
communication). Based on this information, we assume that
the high prevalence of R. helvetica observed in ticks from cats
was not due to R. felis, and therefore, cats may actually be a
reservoir for R. helvetica. In a study from Africa (17), up to
34% of the included cats were found to be seropositive for R.
conorii, another member of the SFG rickettsiae that is trans-
mitted by Rhipicephalus sanguineus. Those authors concluded
that cats can be used as indicators for the presence of these
organisms (17).
Due to the high abundance and the broad host range of I.
ricinus and the high prevalence of R. helvetica in this tick species,
the likelihood of transmission of the agent to tick-exposed indi-
viduals should be high. Nonetheless, all the blood samples from
different mammals, including wild animals (foxes) and human
patients, tested PCR negative. Several reasons have to be consid-
ered to explain this unexpected result. First, the sensitivity of our
PCR assay may not have been sufficient. Rickettsia loads may be
very low, as has been shown for Rickettsia rickettsii in rickettsemic
patients (5, 11, 12). However, this seems very unlikely, given that
the lower detection limit of the applied PCR assay was one copy
per reaction and as little as 100 copies/ml blood could still be
detected in a spike experiment. In addition, the NA extracted
from blood samples did not inhibit the PCRs, in contrast to the
NA from some tick samples. A second explanation could be a
very focal distribution of R. helvetica, leading to high geographical
variations in prevalence. This also seems unlikely, because in the
present study, the majority of ticks and blood samples originated
from the same region (Canton of Zurich). A third explanation
could be a seasonal occurrence of rickettsemia associated with the
seasonal fluctuation of the tick vector I. ricinus; we aimed to avoid
this potential source of bias by collecting canine blood samples
throughout the year. The lack of detection of R. helvetica in blood
samples could also have resulted from a short-lived bacteremia.
This has been demonstrated for other rickettsiae, such as R.
rickettsii, which were detectable for up to only 10 days after ex-
perimental infection of dogs (12, 23). Thus, infection may indeed
have taken place, but the time point of the blood collection may
not have been optimal for detection of infection. However, if
bacteremia is short-lived in large mammals, the likelihood that
they are a major reservoir for R. helvetica is low.
Nonetheless, despite the fact that all the blood samples
tested PCR negative, the pathogenic potential of R. helvetica in
animals should not be overlooked. For comparison, the 1,880
ticks collected from vegetation in the Canton of Zurich were
analyzed not only for R. helvetica but also for TBEV, the
infectious agent that causes encephalitis in humans and Cani-
dae. The exposure risk of R. helvetica was found to be 13 times
higher (prevalence, 11.7%) than that of TBEV (prevalence,
0.9%). Therefore, we anticipate that R. helvetica infections may
also occur in Swiss individuals, as has been demonstrated in
other countries with a high prevalence of R. helvetica in I.
ricinus ticks (8, 18). Further studies are necessary to clarify this
issue. The ability of our newly developed real-time PCR assay
to detect even very low copy numbers and the specific nature of
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our assay make it a valuable tool for further evaluation of the
importance of R. helvetica infections.
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